MAPS Announces Appointment of Tamas Koncz, MD, MSc, PhD to Board of Directors
MAPS is excited to announce the appointment of Tamas Koncz, MD, MSc, PhD, Chief Medical Officer for the Inflammation and Immunology Business at Pfizer, to the MAPS Board of Directors.